Analysts’ Price Target Changes for November 11th (AESI, AII, ALH, AMBQ, AMRC, APEI, ATRO, AWK, BBOT, BCAX)

Analysts’ price target changes for Wednesday, November 11th:

Atlas Energy Solutions (NYSE:AESI) had its target price trimmed by Barclays from $13.00 to $7.00. The firm currently has an equal weight rating on the stock.

Atlas Energy Solutions (NYSE:AESI) had its target price trimmed by Citigroup from $17.00 to $16.00. The firm currently has a buy rating on the stock.

American Integrity Insurance Group (NYSE:AII) had its target price boosted by Citizens Jmp from $29.00 to $32.00. They currently have a market outperform rating on the stock.

Alliance Laundry (NYSE:ALH) had its price target cut by Robert W. Baird from $34.00 to $30.00. The firm currently has an outperform rating on the stock.

Alliance Laundry (NYSE:ALH) had its target price increased by Morgan Stanley from $28.00 to $29.00. Morgan Stanley currently has an equal weight rating on the stock.

Alliance Laundry (NYSE:ALH) had its price target reduced by JPMorgan Chase & Co. from $32.00 to $31.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Ambiq Micro (NYSE:AMBQ) had its price target trimmed by Stifel Nicolaus from $85.00 to $70.00. They currently have a buy rating on the stock.

Ambiq Micro (NYSE:AMBQ) had its target price cut by Needham & Company LLC from $85.00 to $65.00. Needham & Company LLC currently has a buy rating on the stock.

Ameresco (NYSE:AMRC) had its target price trimmed by Stifel Nicolaus from $38.00 to $37.00. Stifel Nicolaus currently has a buy rating on the stock.

American Public Education (NASDAQ:APEI) had its price target trimmed by Truist Financial from $55.00 to $41.00. They currently have a hold rating on the stock.

Astronics (NASDAQ:ATRO) had its target price reduced by TD Cowen from $90.00 to $80.00. The firm currently has a buy rating on the stock.

American Water Works (NYSE:AWK) had its price target increased by Argus from $155.00 to $165.00. The firm currently has a buy rating on the stock.

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) had its price target cut by Wedbush to $9.00. Wedbush currently has an outperform rating on the stock.

Bicara Therapeutics (NASDAQ:BCAX) had its target price reduced by HC Wainwright from $42.00 to $36.00. They currently have a buy rating on the stock.

Bain Capital Specialty Finance (NYSE:BCSF) had its price target cut by Wells Fargo & Company from $12.00 to $11.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Beam Therapeutics (NASDAQ:BEAM) had its price target boosted by Wedbush from $30.00 to $33.00. The firm currently has an outperform rating on the stock.

Bausch Health Cos (NYSE:BHC) had its target price raised by Barclays from $7.00 to $9.00. They currently have an equal weight rating on the stock.

BILL (NYSE:BILL) had its price target raised by Morgan Stanley from $60.00 to $64.00. The firm currently has an equal weight rating on the stock.

Bullish (NYSE:BLSH) had its target price boosted by JPMorgan Chase & Co. from $25.00 to $28.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Black Rock Coffee Bar (NASDAQ:BRCB) had its price target raised by Robert W. Baird from $8.00 to $10.00. The firm currently has a neutral rating on the stock.

Bitdeer Technologies Group (NASDAQ:BTDR) had its target price lowered by Needham & Company LLC from $20.00 to $18.00. Needham & Company LLC currently has a buy rating on the stock.

Bitdeer Technologies Group (NASDAQ:BTDR) had its price target lowered by Barclays from $17.00 to $14.00. The firm currently has an overweight rating on the stock.

BrightView (NYSE:BV) had its target price reduced by Robert W. Baird from $14.00 to $12.00. Robert W. Baird currently has an outperform rating on the stock.

Camden National (NASDAQ:CAC) had its price target raised by Stephens from $58.00 to $59.00. Stephens currently has an equal weight rating on the stock.

Canaan (NASDAQ:CAN) had its price target trimmed by BTIG Research from $2.00 to $1.00. The firm currently has a buy rating on the stock.

Carlsmed (NASDAQ:CARL) had its price target boosted by Truist Financial from $20.00 to $23.00. They currently have a buy rating on the stock.

Carlsmed (NASDAQ:CARL) had its target price raised by BTIG Research from $24.00 to $26.00. They currently have a buy rating on the stock.

Carlsmed (NASDAQ:CARL) had its price target increased by Needham & Company LLC from $17.00 to $22.00. Needham & Company LLC currently has a buy rating on the stock.

Crescent Capital BDC (NASDAQ:CCAP) had its price target cut by Wells Fargo & Company from $11.00 to $10.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Cullinan Therapeutics (NASDAQ:CGEM) had its target price boosted by Wedbush from $42.00 to $44.00. The firm currently has an outperform rating on the stock.

Core & Main (NYSE:CNM) had its price target lowered by Barclays from $61.00 to $60.00. They currently have an overweight rating on the stock.

Core & Main (NYSE:CNM) had its target price lowered by Robert W. Baird from $57.00 to $54.00. They currently have an outperform rating on the stock.

Concentra Group Holdings Parent (NYSE:CON) had its price target increased by Royal Bank Of Canada from $42.00 to $49.00. The firm currently has an outperform rating on the stock.

Costco Wholesale (NASDAQ:COST) had its price target increased by Sanford C. Bernstein from $1,143.00 to $1,155.00. The firm currently has an outperform rating on the stock.

Camden Property Trust (NYSE:CPT) had its price target trimmed by Morgan Stanley from $118.00 to $107.00. They currently have an equal weight rating on the stock.

CoreWeave (NASDAQ:CRWV) had its target price raised by Citigroup from $128.00 to $149.00. The firm currently has a buy rating on the stock.

CoreWeave (NASDAQ:CRWV) had its target price reduced by DA Davidson from $100.00 to $45.00. They currently have a neutral rating on the stock.

CoreWeave (NASDAQ:CRWV) had its price target trimmed by Truist Financial from $165.00 to $115.00. They currently have a buy rating on the stock.

CoreWeave (NASDAQ:CRWV) had its target price reduced by Cantor Fitzgerald from $176.00 to $100.00. Cantor Fitzgerald currently has an overweight rating on the stock.

CoreWeave (NASDAQ:CRWV) had its target price reduced by Stifel Nicolaus from $120.00 to $60.00. Stifel Nicolaus currently has a hold rating on the stock.

Camping World (NYSE:CWH) had its price target trimmed by Truist Financial from $10.00 to $7.00. Truist Financial currently has a buy rating on the stock.

Casella Waste Systems (NASDAQ:CWST) had its target price raised by Barclays from $104.00 to $109.00. They currently have an overweight rating on the stock.

American Axle & Manufacturing (NYSE:DCH) had its target price cut by Barclays from $8.00 to $6.00. They currently have an equal weight rating on the stock.

Doximity (NYSE:DOCS) had its target price raised by Barclays from $27.00 to $30.00. Barclays currently has an equal weight rating on the stock.

Draganfly (NASDAQ:DPRO) had its price target cut by Needham & Company LLC from $8.00 to $6.00. They currently have a buy rating on the stock.

Leonardo DRS (NASDAQ:DRS) had its target price trimmed by JPMorgan Chase & Co. from $53.00 to $48.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Ecovyst (NYSE:ECVT) had its target price cut by Citigroup from $13.00 to $12.00. Citigroup currently has a neutral rating on the stock.

EPAM Systems (NYSE:EPAM) had its price target increased by Citigroup from $140.00 to $172.00. The firm currently has a neutral rating on the stock.

Eupraxia Pharmaceuticals (NASDAQ:EPRX) had its price target boosted by HC Wainwright from $11.00 to $16.00. HC Wainwright currently has a buy rating on the stock.

EquipmentShare.com (NASDAQ:EQPT) had its price target cut by Wells Fargo & Company from $19.00 to $17.00. Wells Fargo & Company currently has an overweight rating on the stock.

Essex Property Trust (NYSE:ESS) had its price target reduced by Morgan Stanley from $302.00 to $285.00. The firm currently has an equal weight rating on the stock.

eToro Group (NASDAQ:ETOR) had its price target cut by TD Cowen from $33.00 to $26.00. TD Cowen currently has a buy rating on the stock.

eToro Group (NASDAQ:ETOR) had its target price lowered by Canaccord Genuity Group from $47.00 to $40.00. They currently have a buy rating on the stock.

eToro Group (NASDAQ:ETOR) had its price target trimmed by Needham & Company LLC from $54.00 to $45.00. Needham & Company LLC currently has a buy rating on the stock.

Edwards Lifesciences (NYSE:EW) had its target price boosted by TD Cowen from $117.00 to $121.00. They currently have a buy rating on the stock.

Expedia Group (NASDAQ:EXPE) had its price target trimmed by Argus from $360.00 to $300.00. Argus currently has a buy rating on the stock.

Funding Circle (LON:FCH) had its target price boosted by Canaccord Genuity Group from GBX 308 to GBX 315. Canaccord Genuity Group currently has a buy rating on the stock.

FactSet Research Systems (NYSE:FDS) had its price target increased by Stifel Nicolaus from $292.00 to $325.00. The firm currently has a hold rating on the stock.

FactSet Research Systems (NYSE:FDS) had its price target boosted by Morgan Stanley from $300.00 to $321.00. They currently have an equal weight rating on the stock.

Fidelity National Information Services (NYSE:FIS) had its target price lowered by Sanford C. Bernstein from $48.00 to $31.00. Sanford C. Bernstein currently has a market perform rating on the stock.

Fiserv (NASDAQ:FISV) had its price target increased by Citigroup from $62.00 to $67.00. The firm currently has a neutral rating on the stock.

Fiserv (NASDAQ:FISV) had its target price raised by Sanford C. Bernstein from $60.00 to $70.00. Sanford C. Bernstein currently has a market perform rating on the stock.

Five Below (NASDAQ:FIVE) had its price target raised by Sanford C. Bernstein from $272.00 to $279.00. The firm currently has an outperform rating on the stock.

Firefly Aerospace (NASDAQ:FLY) had its target price increased by B. Riley Financial from $40.00 to $54.00. The firm currently has a buy rating on the stock.

Firefly Aerospace (NASDAQ:FLY) had its target price raised by Barclays from $34.00 to $35.00. They currently have an equal weight rating on the stock.

Flywire (NASDAQ:FLYW) had its target price boosted by Truist Financial from $19.00 to $23.00. Truist Financial currently has a hold rating on the stock.

Forgent Power Solutions (NYSE:FPS) had its target price reduced by JPMorgan Chase & Co. from $49.00 to $35.00. They currently have an overweight rating on the stock.

FS KKR Capital (NYSE:FSK) had its target price raised by B. Riley Financial from $11.00 to $12.00. The firm currently has a neutral rating on the stock.

GE HealthCare Technologies (NASDAQ:GEHC) had its price target raised by Argus from $85.00 to $110.00. The firm currently has a buy rating on the stock.

Gen Digital (NASDAQ:GEN) had its target price raised by Argus from $32.00 to $35.00. The firm currently has a buy rating on the stock.

GE Vernova (NYSE:GEV) had its target price lowered by JPMorgan Chase & Co. from $1,035.00 to $1,000.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

GFL Environmental (NYSE:GFL) had its target price trimmed by JPMorgan Chase & Co. from $42.00 to $40.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.

Gilat Satellite Networks (NASDAQ:GILT) had its price target lowered by Needham & Company LLC from $20.00 to $11.00. The firm currently has a buy rating on the stock.

GMR Solutions (NYSE:GMRS) had its target price cut by Citigroup from $17.00 to $15.00. They currently have a buy rating on the stock.

Grocery Outlet (NASDAQ:GO) had its price target raised by TD Cowen from $12.00 to $14.00. TD Cowen currently has a hold rating on the stock.

Grocery Outlet (NASDAQ:GO) had its price target raised by Wells Fargo & Company from $11.00 to $13.00. They currently have an equal weight rating on the stock.

Gossamer Bio (NASDAQ:GOSS) had its price target cut by Wedbush to $32.00. They currently have a neutral rating on the stock.

Global Payments (NYSE:GPN) had its price target boosted by Sanford C. Bernstein from $86.00 to $100.00. Sanford C. Bernstein currently has a market perform rating on the stock.

HIVE Digital Technologies (NASDAQ:HIVE) had its price target reduced by B. Riley Financial from $8.00 to $5.00. They currently have a buy rating on the stock.

HIVE Digital Technologies (NASDAQ:HIVE) had its price target cut by HC Wainwright from $6.00 to $5.00. They currently have a buy rating on the stock.

Herbalife (NYSE:HLF) had its target price raised by Argus from $15.00 to $20.00. Argus currently has a buy rating on the stock.

Horizon Quantum Computing Pte. (NASDAQ:HQ) had its target price lowered by Needham & Company LLC from $20.00 to $19.00. They currently have a buy rating on the stock.

Hilltop (NYSE:HTH) had its price target reduced by Piper Sandler from $42.00 to $36.00. They currently have a neutral rating on the stock.

Hubbell (NYSE:HUBB) had its target price lowered by JPMorgan Chase & Co. from $486.00 to $470.00. They currently have a neutral rating on the stock.

Humana (NYSE:HUM) had its price target increased by TD Cowen from $370.00 to $430.00. TD Cowen currently has a hold rating on the stock.

Humacyte (NASDAQ:HUMA) had its target price raised by Barclays from $0.50 to $0.60. They currently have an equal weight rating on the stock.

Opus Genetics (NASDAQ:IRD) had its target price boosted by Royal Bank Of Canada from $9.00 to $11.00. They currently have an outperform rating on the stock.

Opus Genetics (NASDAQ:IRD) had its price target increased by HC Wainwright from $8.00 to $14.00. The firm currently has a buy rating on the stock.

iRhythm Technologies (NASDAQ:IRTC) had its target price trimmed by Stephens from $160.00 to $120.00. Stephens currently has an overweight rating on the stock.

Janus International Group (NYSE:JBI) had its target price reduced by KeyCorp from $9.00 to $7.00. They currently have an overweight rating on the stock.

KKR & Co. Inc. (NYSE:KKR) had its target price boosted by Piper Sandler from $121.00 to $125.00. The firm currently has an overweight rating on the stock.

Lucid Group (NASDAQ:LCID) had its price target lowered by Citigroup from $11.00 to $9.00. They currently have a buy rating on the stock.

Legacy Housing (NASDAQ:LEGH) had its price target increased by B. Riley Financial from $24.00 to $27.00. The firm currently has a neutral rating on the stock.

Legend Biotech (NASDAQ:LEGN) had its price target reduced by Royal Bank Of Canada from $56.00 to $50.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Legend Biotech (NASDAQ:LEGN) had its price target lowered by Barclays from $68.00 to $61.00. Barclays currently has an overweight rating on the stock.

Legend Biotech (NASDAQ:LEGN) had its price target cut by Morgan Stanley from $49.00 to $43.00. The firm currently has an overweight rating on the stock.

Legend Biotech (NASDAQ:LEGN) had its target price reduced by Oppenheimer from $40.00 to $25.00. Oppenheimer currently has a market perform rating on the stock.

Ligand Pharmaceuticals (NASDAQ:LGND) had its target price increased by Barclays from $345.00 to $350.00. They currently have an overweight rating on the stock.

Life360 (NASDAQ:LIF) had its price target cut by Citigroup from $60.00 to $56.60. The firm currently has a buy rating on the stock.

Lineage (NASDAQ:LINE) had its price target trimmed by Robert W. Baird from $43.00 to $40.00. Robert W. Baird currently has a neutral rating on the stock.

Liquidia (NASDAQ:LQDA) had its price target increased by Needham & Company LLC from $58.00 to $66.00. They currently have a buy rating on the stock.

Liquidia (NASDAQ:LQDA) had its target price boosted by Wells Fargo & Company from $33.00 to $40.00. They currently have an equal weight rating on the stock.

Landstar System (NASDAQ:LSTR) had its target price reduced by Morgan Stanley from $145.00 to $130.00. They currently have an underweight rating on the stock.

LuxExperience B.V. (NYSE:LUXE) had its target price raised by TD Cowen from $11.00 to $12.00. TD Cowen currently has a buy rating on the stock.

Mastercard (NYSE:MA) had its price target boosted by Sanford C. Bernstein from $730.00 to $764.00. They currently have an outperform rating on the stock.

MARA (NASDAQ:MARA) had its price target lowered by JPMorgan Chase & Co. from $11.00 to $9.00. The firm currently has an underweight rating on the stock.

908 Devices (NASDAQ:MASS) had its target price increased by Stifel Nicolaus from $12.00 to $14.00. The firm currently has a buy rating on the stock.

Maze Therapeutics (NASDAQ:MAZE) had its target price cut by JPMorgan Chase & Co. from $53.00 to $51.00. They currently have an overweight rating on the stock.

Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target increased by Citigroup from $184.00 to $194.00. They currently have a buy rating on the stock.

Martin Marietta Materials (NYSE:MLM) had its target price raised by Stifel Nicolaus from $629.00 to $653.00. They currently have a buy rating on the stock.

Mplx (NYSE:MPLX) had its target price cut by Barclays from $63.00 to $61.00. The firm currently has an overweight rating on the stock.

Morgan Stanley Direct Lending Fund (NYSE:MSDL) had its price target lowered by Royal Bank Of Canada from $16.00 to $14.00. The firm currently has a sector perform rating on the stock.

MSC Income Fund (NYSE:MSIF) had its target price raised by B. Riley Financial from $13.00 to $14.00. They currently have a buy rating on the stock.

NewAmsterdam Pharma (NASDAQ:NAMS) had its price target increased by Cantor Fitzgerald from $52.00 to $61.00. Cantor Fitzgerald currently has an overweight rating on the stock.

National Fuel Gas (NYSE:NFG) had its target price trimmed by KeyCorp from $95.00 to $91.00. KeyCorp currently has an overweight rating on the stock.

Northern Oil and Gas (NYSE:NOG) had its target price lowered by Citigroup from $32.00 to $30.00. Citigroup currently has a buy rating on the stock.

Energy Vault (NYSE:NRGV) had its price target raised by Cantor Fitzgerald from $7.00 to $12.00. They currently have an overweight rating on the stock.

nVent Electric (NYSE:NVT) had its target price reduced by JPMorgan Chase & Co. from $167.00 to $155.00. They currently have an overweight rating on the stock.

NexGen Energy (NYSE:NXE) had its price target reduced by JPMorgan Chase & Co. from $14.00 to $12.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

ON (NYSE:ONON) had its target price boosted by JPMorgan Chase & Co. from $44.00 to $46.00. The firm currently has an overweight rating on the stock.

ON (NYSE:ONON) had its price target cut by Barclays from $44.00 to $42.00. They currently have an overweight rating on the stock.

ON (NYSE:ONON) had its price target raised by KeyCorp from $37.00 to $42.00. The firm currently has an overweight rating on the stock.

ON (NYSE:ONON) had its target price raised by Morgan Stanley from $39.00 to $43.00. They currently have an overweight rating on the stock.

Occidental Petroleum (NYSE:OXY) had its target price lowered by Wells Fargo & Company from $82.00 to $76.00. Wells Fargo & Company currently has an overweight rating on the stock.

Plains All American Pipeline (NASDAQ:PAA) had its price target raised by Wells Fargo & Company from $23.00 to $25.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Plains All American Pipeline (NASDAQ:PAA) had its price target raised by Barclays from $24.00 to $25.00. The firm currently has an underweight rating on the stock.

Plains GP (NYSE:PAGP) had its price target raised by Barclays from $24.00 to $25.00. Barclays currently has an underweight rating on the stock.

Plains GP (NYSE:PAGP) had its price target increased by Wells Fargo & Company from $23.00 to $25.00. They currently have an equal weight rating on the stock.

Palisade Bio (NASDAQ:PALI) had its price target trimmed by HC Wainwright to $5.00. HC Wainwright currently has a buy rating on the stock.

PepGen (NASDAQ:PEPG) had its target price boosted by Wedbush from $4.00 to $10.00. The firm currently has an outperform rating on the stock.

P3 Health Partners (NASDAQ:PIII) had its price target cut by TD Cowen from $13.00 to $4.00. TD Cowen currently has a hold rating on the stock.

Plug Power (NASDAQ:PLUG) had its target price cut by Susquehanna from $1.75 to $1.50. Susquehanna currently has a neutral rating on the stock.

PayPal (NASDAQ:PYPL) had its price target increased by Sanford C. Bernstein from $55.00 to $60.00. The firm currently has a market perform rating on the stock.

D-Wave Quantum (NASDAQ:QBTS) had its target price reduced by Stifel Nicolaus from $35.00 to $23.00. Stifel Nicolaus currently has a buy rating on the stock.

D-Wave Quantum (NASDAQ:QBTS) had its target price trimmed by Rosenblatt Securities from $43.00 to $30.00. The firm currently has a buy rating on the stock.

D-Wave Quantum (NASDAQ:QBTS) had its target price reduced by Needham & Company LLC from $40.00 to $20.00. The firm currently has a buy rating on the stock.

QumulusAI (NASDAQ:QMLS) had its price target trimmed by Chardan Capital to $13.00. They currently have a buy rating on the stock.

QumulusAI (NASDAQ:QMLS) had its target price cut by B. Riley Financial from $11.00 to $9.00. The firm currently has a buy rating on the stock.

QuickLogic (NASDAQ:QUIK) had its target price trimmed by Needham & Company LLC from $20.00 to $12.00. Needham & Company LLC currently has a buy rating on the stock.

RB Global (NYSE:RBA) (TSE:RBA) had its target price boosted by Barclays from $110.00 to $112.00. Barclays currently has an overweight rating on the stock.

RideNow Group (NASDAQ:RDNW) had its target price trimmed by Robert W. Baird from $9.00 to $5.50. Robert W. Baird currently has a neutral rating on the stock.

Resideo Technologies (NYSE:REZI) had its target price reduced by Oppenheimer from $27.00 to $25.00. Oppenheimer currently has an outperform rating on the stock.

Rigetti Computing (NASDAQ:RGTI) had its price target lowered by Needham & Company LLC from $31.00 to $15.00. The firm currently has a buy rating on the stock.

Rocket Lab (NASDAQ:RKLB) had its target price lowered by Needham & Company LLC from $120.00 to $100.00. They currently have a buy rating on the stock.

Rocket Lab (NASDAQ:RKLB) had its target price lowered by Morgan Stanley from $105.00 to $103.00. They currently have an overweight rating on the stock.

Regal Rexnord (NYSE:RRX) had its target price reduced by JPMorgan Chase & Co. from $196.00 to $195.00. They currently have an overweight rating on the stock.

Satellogic (NASDAQ:SATL) had its target price reduced by Cantor Fitzgerald from $9.00 to $7.00. Cantor Fitzgerald currently has an overweight rating on the stock.

Sally Beauty (NYSE:SBH) had its price target boosted by Morgan Stanley from $13.00 to $19.00. Morgan Stanley currently has an underweight rating on the stock.

SEA (NYSE:SE) had its price target cut by TD Cowen from $100.00 to $90.00. The firm currently has a hold rating on the stock.

Solaris Energy Infrastructure (NYSE:SEI) had its price target increased by Needham & Company LLC from $104.00 to $126.00. Needham & Company LLC currently has a buy rating on the stock.

Surgery Partners (NASDAQ:SGRY) had its target price boosted by TD Cowen from $23.50 to $25.00. The firm currently has a hold rating on the stock.

Sonida Senior Living (NYSE:SNDA) had its price target cut by Royal Bank Of Canada from $48.00 to $43.00. They currently have an outperform rating on the stock.

Spire Global (NYSE:SPIR) had its price target trimmed by Stifel Nicolaus from $24.00 to $20.00. Stifel Nicolaus currently has a buy rating on the stock.

SPX Technologies (NYSE:SPXC) had its target price trimmed by JPMorgan Chase & Co. from $225.00 to $190.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

STUB (NYSE:STUB) had its price target trimmed by JPMorgan Chase & Co. from $11.00 to $8.00. The firm currently has a neutral rating on the stock.

Starwood Property Trust (NYSE:STWD) had its target price trimmed by JPMorgan Chase & Co. from $16.00 to $15.50. They currently have an overweight rating on the stock.

Stereotaxis (NYSEAMERICAN:STXS) had its target price cut by TD Cowen from $3.00 to $2.00. TD Cowen currently has a buy rating on the stock.

Tatton Asset Management (LON:TAM) had its target price raised by Berenberg Bank from GBX 820 to GBX 840. Berenberg Bank currently has a buy rating on the stock.

Transdigm Group (NYSE:TDG) had its target price raised by Royal Bank Of Canada from $1,200.00 to $1,300.00. They currently have a sector perform rating on the stock.

Transdigm Group (NYSE:TDG) had its target price boosted by Morgan Stanley from $1,300.00 to $1,405.00. The firm currently has an equal weight rating on the stock.

Transdigm Group (NYSE:TDG) had its target price boosted by TD Cowen from $1,300.00 to $1,350.00. TD Cowen currently has a buy rating on the stock.

TIM (NYSE:TIMB) had its price target trimmed by Barclays from $22.00 to $20.00. Barclays currently has an equal weight rating on the stock.

LON:TIN (LON:TIN) had its target price lowered by Berenberg Bank from GBX 153 to GBX 93. They currently have a buy rating on the stock.

TriSalus Life Sciences (NASDAQ:TLSI) had its target price trimmed by HC Wainwright from $12.00 to $10.00. HC Wainwright currently has a buy rating on the stock.

Trane Technologies (NYSE:TT) had its price target lowered by JPMorgan Chase & Co. from $550.00 to $480.00. The firm currently has an overweight rating on the stock.

Trade Desk (NASDAQ:TTD) had its price target raised by Cantor Fitzgerald from $14.00 to $15.00. The firm currently has a neutral rating on the stock.

Trade Desk (NASDAQ:TTD) had its target price boosted by Piper Sandler from $14.00 to $16.00. Piper Sandler currently has a neutral rating on the stock.

Trade Desk (NASDAQ:TTD) had its price target raised by Wells Fargo & Company from $12.00 to $15.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Tyra Biosciences (NASDAQ:TYRA) had its price target lowered by HC Wainwright from $29.00 to $27.00. They currently have a buy rating on the stock.

Tyra Biosciences (NASDAQ:TYRA) had its target price boosted by Wedbush from $53.00 to $57.00. Wedbush currently has an outperform rating on the stock.

United Dominion Realty Trust (NYSE:UDR) had its target price cut by Morgan Stanley from $42.00 to $41.00. They currently have an equal weight rating on the stock.

Universal Health Services (NYSE:UHS) had its price target raised by Royal Bank Of Canada from $183.00 to $207.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

Upstream Bio (NASDAQ:UPB) had its target price cut by HC Wainwright to $18.00. They currently have a buy rating on the stock.

Ur Energy (NYSEAMERICAN:URG) (TSE:URE) had its target price lowered by Royal Bank Of Canada from $1.60 to $1.25. Royal Bank Of Canada currently has an outperform rating on the stock.

Visa (NYSE:V) had its target price boosted by Sanford C. Bernstein from $475.00 to $486.00. The firm currently has an outperform rating on the stock.

Veracyte (NASDAQ:VCYT) had its price target lowered by Stephens from $55.00 to $40.00. Stephens currently has an overweight rating on the stock.

Veeva Systems (NYSE:VEEV) had its price target boosted by Wells Fargo & Company from $330.00 to $400.00. Wells Fargo & Company currently has an overweight rating on the stock.

WESCO International (NYSE:WCC) had its price target raised by Barclays from $437.00 to $450.00. They currently have an overweight rating on the stock.

Winnebago Industries (NYSE:WGO) had its target price increased by Truist Financial from $35.00 to $39.00. Truist Financial currently has a buy rating on the stock.

Wix.com (NASDAQ:WIX) had its target price reduced by Cantor Fitzgerald from $90.00 to $80.00. The firm currently has an overweight rating on the stock.

Wix.com (NASDAQ:WIX) had its target price cut by Royal Bank Of Canada from $60.00 to $58.00. They currently have a sector perform rating on the stock.

Wix.com (NASDAQ:WIX) had its target price cut by Wells Fargo & Company from $64.00 to $63.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Wix.com (NASDAQ:WIX) had its target price raised by Morgan Stanley from $65.00 to $73.00. They currently have an equal weight rating on the stock.

Wix.com (NASDAQ:WIX) had its price target cut by Citigroup from $72.00 to $71.00. They currently have a neutral rating on the stock.

Whitbread (LON:WTB) had its price target raised by Berenberg Bank from GBX 2,400 to GBX 2,700. Berenberg Bank currently has a hold rating on the stock.

Essential Utilities (NYSE:WTRG) had its target price boosted by Argus from $45.00 to $50.00. They currently have a buy rating on the stock.

Select Water Solutions (NYSE:WTTR) had its price target cut by Citigroup from $24.00 to $23.00. Citigroup currently has a buy rating on the stock.

WhiteFiber (NASDAQ:WYFI) had its target price cut by BTIG Research from $50.00 to $30.00. They currently have a buy rating on the stock.

WhiteFiber (NASDAQ:WYFI) had its price target raised by HC Wainwright from $34.00 to $36.00. They currently have a buy rating on the stock.

WhiteFiber (NASDAQ:WYFI) had its price target lowered by Needham & Company LLC from $41.00 to $37.00. The firm currently has a buy rating on the stock.

Xeris Biopharma (NASDAQ:XERS) had its price target boosted by Barclays from $14.00 to $18.00. They currently have an overweight rating on the stock.

Global Medical REIT (NYSE:XRN) had its price target trimmed by Citizens Jmp from $42.00 to $35.00. They currently have a market outperform rating on the stock.

Block (NYSE:XYZ) had its price target increased by Truist Financial from $89.00 to $95.00. They currently have a buy rating on the stock.

Block (NYSE:XYZ) had its target price increased by Sanford C. Bernstein from $95.00 to $110.00. They currently have an outperform rating on the stock.

Ziff Davis (NASDAQ:ZD) had its target price cut by Citigroup from $59.00 to $56.00. The firm currently has a neutral rating on the stock.

Zeta Global (NYSE:ZETA) had its price target boosted by Morgan Stanley from $25.00 to $33.00. Morgan Stanley currently has an equal weight rating on the stock.

Ermenegildo Zegna (NYSE:ZGN) had its target price increased by TD Cowen from $16.00 to $17.00. They currently have a buy rating on the stock.

Zymeworks (NASDAQ:ZYME) had its target price increased by Citigroup from $39.00 to $44.00. Citigroup currently has a buy rating on the stock.